ADAR1 Capital Management, LLC
Q2 2025 13F Holdings
- Locationaustin, TX
- Num holdings
210
- Value ($000)
$652,088
- Date Filed08/14/2025
- Form type13F-HR
- CIK0001940272
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
KROS KEROS THERAPEUTICS INC | COM | 492327101 | $71.95M | 11 % | 5,389,264 | ||
PTGX PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | $52.40M | 8 % | 948,069 | ||
BOXX EA SERIES TRUST | ALPHA ARCH 1-3 | 02072L565 | $37.99M | 6 % | 337,125 | ||
ZLAB ZAI LAB LTD | ADR | 98887Q104 | $29.74M | 5 % | 850,437 | ||
SPY SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | $25.02M | 4 % | 40,500 | put | |
ABIVAX SA | SPONSORED ADS | 00370M103 | $23.50M | 4 % | 3,071,340 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | $21.87M | 3 % | 1,940,797 | ||
PROTHENA CORP PLC | SHS | G72800108 | $20.49M | 3 % | 3,375,009 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $19.23M | 3 % | 582,147 | ||
SPY SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | $14.02M | 2 % | 22,684 |
Rows Per Page
10
- 10
- 50
- 100